AIHealthcare Analytics

Knowledge Wiki

Wiki › Who Will Regulate The AI Doctors Use? The FDA And The States Disagree

Who Will Regulate The AI Doctors Use? The FDA And The States Disagree

OVERVIEW
Rev 2 Oct 31, 2026 05:42 UTC 1 sources

Forbes analysis documents fundamental disagreement between FDA and states over regulatory authority for AI tools used in clinical practice. The jurisdictional conflict creates compliance uncertainty as states approve autonomous AI systems that may fall under FDA's medical device purview. Regulatory Divide: FDA asserts authority over AI tools that function as medical devices (making clinical recommendations, autonomous decisions). States claim authority over medical practice and licensing, including oversight of clinician use of AI tools. This divide creates situations where state-approved AI systems lack FDA authorization, and vice versa. Practical Conflicts: Utah's autonomous prescribing pilots and other state sandboxes proceed without explicit FDA clearance, creating legal ambiguity. Health systems operating across multiple states face conflicting compliance requirements. The lack of clear federal-state coordination mechanism creates ongoing regulatory uncertainty. ---

Sources: harvested
🔒

Subscribe to read full wiki analysis

Full wiki content — including source provenance, contradiction tracking, related pages, and analyst notes — is available to Subscriber members.

View Plans & Subscribe

New users get a 7-day trial — no credit card required.

← Back to Wiki Index